Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. by Costigan, Michael et al.
BioMed  Central
Page 1 of 18
(page number not for citation purposes)
BMC Neuroscience
Open Access BMC Neuroscience  2002,  3 x Research article
Replicate high-density rat genome oligonucleotide microarrays 
reveal hundreds of regulated genes in the dorsal root ganglion after 
peripheral nerve injury.
Michael Costigan†1, Katia Befort†1, Laurie Karchewski1, Robert S Griffin1, 
Donatella D'Urso2, Andrew Allchorne1, Joanne Sitarski1, 
James W Mannion1, Richard E Pratt3 and Clifford J Woolf*1
Address: 1Neural Plasticity Research Group, Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical 
School, Charlestown, MA 02129, USA, 2Bayer AG, Wuppertal, Germany and 3Department of Medicine, Brigham and Women's Hospital, Harvard 
Medical School, MA 02115, USA
E-mail: Michael Costigan - costigan@helix.mgh.harvard.edu; Katia Befort - befort@titus.u-strasbg.fr; Laurie Karchewski - lkarch@titus.u-
strasbg.fr; Robert S Griffin - robert_griffin@student.hms.harvard.edu; Donatella D'Urso - donatella.durso.dd@bayer-ag.de; 
Andrew Allchorne - aallchorne@partners.org; Joanne Sitarski - joannesitarski@hotmail.com; James W Mannion - mannionjames@hotmail.com; 
Richard E Pratt - repratt@bics.bwh.harvard.edu; Clifford J Woolf* - woolf.clifford@mgh.harvard.edu
*Corresponding author      †Equal contributors
Abstract
Background: Rat oligonucleotide microarrays were used to detect changes in gene expression in
the dorsal root ganglion (DRG) 3 days following sciatic nerve transection (axotomy). Two
comparisons were made using two sets of triplicate microarrays, naïve versus naïve and naïve
versus axotomy.
Results: Microarray variability was assessed using the naïve versus naïve comparison. These results
support use of a P < 0.05 significance threshold for detecting regulated genes, despite the large
number of hypothesis tests required. For the naïve versus axotomy comparison, a 2-fold cut off
alone led to an estimated error rate of 16%; combining a >1.5-fold expression change and P < 0.05
significance reduced the estimated error to 5%. The 2-fold cut off identified 178 genes while the
combined >1.5-fold and P < 0.05 criteria generated 240 putatively regulated genes, which we have
listed. Many of these have not been described as regulated in the DRG by axotomy. Northern blot,
quantitative slot blots and in situ hybridization verified the expression of 24 transcripts. These data
showed an 83% concordance rate with the arrays; most mismatches represent genes with low
expression levels reflecting limits of array sensitivity. A significant correlation was found between
actual mRNA differences and relative changes between microarrays (r2 = 0.8567). Temporal
patterns of individual genes regulation varied.
Conclusions: We identify parameters for microarray analysis which reduce error while identifying
many putatively regulated genes. Functional classification of these genes suggest reorganization of
cell structural components, activation of genes expressed by immune and inflammatory cells and
down-regulation of genes involved in neurotransmission.
Published: 25 October 2002
BMC Neuroscience 2002, 3:16
Received: 29 August 2002
Accepted: 25 October 2002
This article is available from: http://www.biomedcentral.com/1471-2202/3/16
© 2002 Costigan et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
Page 2 of 18
(page number not for citation purposes)
Background
Transection of the peripheral axons of primary sensory
neurons results in profound alterations in their metabo-
lism, regenerative capacity, survival, excitability, transmit-
ter function and sensitivity to diverse extrinsic and
intrinsic signals [1,2]. These changes are contributed to by
transcriptional alterations triggered by a loss of trophic
support from peripheral target organs, and by novel sig-
nals generated at the injury site. The transcriptional
changes lead both to adaptive responses, such as the ca-
pacity to survive the injury and re-grow the injured axon,
and maladaptive responses that can lead to a change in
sensation, including the generation of neuropathic pain
[3,4].
Measurements of mRNA and protein made in many labo-
ratories using diverse methodologies have identified ap-
proximately 40 genes that are up-regulated and 25 down-
regulated after peripheral nerve injury [3,5,6]. These regu-
lated genes include members of several classes: G protein
coupled receptors, ligand- and voltage-gated ion chan-
nels, receptor tyrosine kinases, growth factors, cytokines,
neuropeptides, cell cytoskeletal genes, cell surface/extra-
cellular matrix genes, and a miscellaneous group of en-
zymes.
We have now used high-density rat genome oligonucle-
otide microarrays to analyze changes in gene expression at
an early time point (3 days) following a peripheral nerve
injury in adult rats. Oligonucleotide microarrays provide
the capacity to analyze parallel changes in many thou-
sands of genes, and have been used successfully to exam-
ine expression profile changes in many neuronal and non-
neuronal systems [7] including DRG neurons [8,9]. Stud-
ying the effect of peripheral nerve injury on gene expres-
sion profiles in the DRG offers several advantages. The
DRG represents a dense collection of cell bodies of one
general class of neuron, the primary sensory neuron. The
lesion has a uniform impact on the cells, and the existence
of a large pool of genes with known regulation allows for
quality controls for changes identified by the microarrays
[3,5,6].
Although microarrray technology offers enormous poten-
tial advantages, there remain important concerns about
representation, sensitivity, reproducibility, variability and
the false positive and negative detection rates [10,11].
What, if any, is the threshold fold-difference between
probe sets that reflects real regulation? Is fold-difference
the most sensitive measure for detecting changes? Are
genes with a low expression levels in all conditions detect-
ed? What is the concordance rate between genes identified
as regulated by independent methods and genes identi-
fied by the microarray analysis? What criteria need to be
used to jointly minimize the false negative and the false
positive rates? How many arrays need to be analyzed?
We now show that fold-difference alone results in a high
degree of error whilst detecting regulated genes from
microarrays, replicate arrays with statistical analysis re-
duces false positives and negatives. The oligonucleotide
microarray screen indicates that hundreds of genes are
regulated by neuronal injury, and that this technique is a
powerful primary screen for such changes.
Results
Array sensitivity and variability
Affymetrix rat U34A oligonucleotide arrays were used to
screen for changes in gene expression in DRG neurons
three days following a peripheral nerve transection (axot-
omy, Ax) by comparing expression levels with non-in-
jured DRGs (naïve, N). Nine biologically independent
array hybridizations were performed (six naïve and three
axotomy). DRG tissue (L4 and L5 from the left or ipsilat-
eral side to the injury) from 5 male Sprague-Dawley rats
were pooled for each RNA population. Each RNA sample
was labeled separately and hybridized to a separate array.
Genes were defined as detected if they received a present
or marginal call in at least one of the arrays within each
comparison. Of the 8799 annotated genes and expressed
sequence tags (ESTs) represented on the rat U34A array,
52% (n= 6, naïve arrays) were detected in arrays hybrid-
ized with naïve rat DRG cRNA and 54% (n = 3, axotomy
arrays) genes in the axotomy comparisons.
To assess the degree of variability inherent in the system,
the mean probe set intensity values of the two independ-
ent sets of three naïve samples were compared on a scatter
plot (Figure 1A). The majority of probe sets from the two
control groups (N vs. N) lie on or very close to the identity
line, with a linear regression of r2 = 0.9898 (for all detect-
ed genes in the N vs. N comparison, Figure 1A). Figure 1A
shows that most of the variation between the two naïve
groups exists at the lower end of the gene expression lev-
els. This suggests that this variability is in part due to array
sensitivity. In consequence, differences in low intensity
genes may be unreliable.
A plot of the mean intensity from triplicate naives against
triplicate 3 day axotomy (N vs. Ax) arrays (Figure 1B)
show many data points lying both above and below the
identity line, suggesting regulation. Since each individual
sample was pooled from 5 male Sprague-Dawley animals
of a similar age and from a single supplier (Charles River),
biological variation is likely to be minimal.
Defining regulated genes
Many of the detected genes in both the N vs. N and the N
vs. Ax array comparison groups show no difference, de-BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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Figure 1
Intensity plots of average values of all present genes for the naïve group 1 versus naïve group 2. (A) and the naïve group 1 ver-
sus the 3 day axotomy group (B). Intensity plots of average values of all genes deemed to vary significantly using an unpaired
two-tailed t-test, for the naïve group 1 versus naïve group 2 comparison (C) and the naïve group 1 versus the 3 day axotomy
group comparison (D). Plots are color coded so that P < 0.05 (blue points), P < 0.01 (green points), P < 0.001 (red points).
Tabulated in (E) are the numbers of genes detected (grey) and those genes achieving P < 0.05 (blue), P < 0.01 (green), P <
0.001 (red) as a function of fold change.
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AB
CD
Fold difference 1.0 to 1.15 1.15 to 1.25 1.25 to 1.5 1.5 to 1.75 1.75 to 2 2 to 2.5 2.5 to 5 over 5 Sum % Sum %
Any P Naïve vs naïve 3189 768 491 89 33 9 17 2 4598 100.0 150 3.3
Naïve vs axotomy 2236 967 967 280 89 90 62 26 4717 100.0 547 11.6
P < 0.05 Naïve vs naïve 11 45 41 7 3 1 1 0 109 2.40 12 0.26
Naïve vs axotomy 24 73 219 97 49 45 33 16 556 11.80 240 5.09
P < 0.01 Naïve vs naïve 3 1 4 2 2 0 1 0 13 0.28 5 0.11
Naïve vs axotomy 3 12 32 27 20 21 15 14 144 3.10 97 2.06
P < 0.001 Naïve vs naïve 0 0 0 1 0 0 0 0 1 0.02 1 0.02
Naïve vs axotomy 0 1 2 2 1 7 5 5 23 0.49 20 0.42
Genes > 1.5 fold All genes
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fined as fold-difference up or down less than 1.15 (69%,
N vs. N and 47%, N vs. Ax) (Figure 1E). Further, many
show small fold-differences of 1.15 to 1.5 (27%, N vs. N
and 41%, N vs. Ax) (Figure 1E). In total, genes displaying
a fold-difference below 1.5-fold accounted for 97% of the
N vs. N arrays and 88% of the N vs. Ax comparison.
When statistical significance is not taken into account,
122 genes display a difference of 1.5–2.0 fold and 28 a
greater than 2-fold difference in the N vs. N group (2.6%
and 0.6% of present genes respectively). In the N vs. Ax
group 369 genes show a fold-difference of 1.5–2.0 and
178 greater than 2-fold (7.8% and 3.8% of present genes
respectively). Although a greater than 2-fold change cut
off eliminates most false positives (estimated error rate,
16%), this specificity is at the expense of many putatively
regulated genes. In the 1.5–2.0 fold range in the N vs. Ax
group, there are still three times as many genes as are in
the N vs. N group. (369 genes [N vs. Ax] vs. 122 genes [N
vs. N]; Figure 1E).
In order to distinguish systematic from random differenc-
es in the array intensity levels, a two-tailed t-test was per-
formed for both comparison groups, which was possible
since each group consisted of three independent experi-
ments. One of the fundamental problems in analyzing
microarray data is the risk of false positive results due to
multiple hypothesis testing. The most conservative ap-
proach to this problem, a Bonferroni-corrected signifi-
cance threshold, would not result in any significantly
regulated genes, as the adjusted threshold would be 1.06
× 10-5, while the lowest P value attained in our data set for
the N vs. Ax. comparison was 1.51 × 10-5. This would also
rule out identification of genes via step-down methods
based on the Bonferroni correction. Therefore, we at-
tempted to assess the accumulation of false positives em-
pirically, by testing multiple hypotheses in our system on
a sample not expected to include any true positives, i.e.
the N. vs. N. comparison. Those probe sets with a unad-
justed significance of P < 0.05 (blue), P < 0.01 (green) or
P < 0.001 (red) are indicated on the scatter plots in Figures
1C and 1D, while the distribution of significant differenc-
es at different fold-changes is illustrated in the table in Fig-
ure 1E. Of the 4599 detected genes in the naïve samples,
109 show a significant difference between the two sets
(2.4%, P < 0.05). The vast majority of these genes, howev-
er, exhibit low fold changes (<1.5-fold, 89%, Figure 1E).
Of the 369 genes that show a fold-difference of 1.5–2.0
and the 178 that were above 2-fold in the N vs. Ax com-
parison, 223 (60%) and 84 (57%) respectively were not
significant (Figure 1E, P < 0.05). These data indicate that
using a fold-difference of greater than 2 from triplicate
samples to select regulated genes will include many false
positives. However, combining fold difference with signif-
icant difference in a two dimensional matrix can reduce
the false positive error rate drastically. The combination of
a >1.5-fold and significant difference (P < 0.05) identifies
12 genes in the N vs. N comparison compared with 240
genes for N vs. Ax, a 20-fold difference (Figure 1E). The es-
timated error of 5% using these two criteria is much less
than that obtained using just above 2-fold (16%) or sig-
nificance alone (20%) and prevents many genes regulated
below 2-fold being excluded from consideration of regu-
lation.
The inherent array error rate (determined by the signifi-
cant difference rate in the N vs. N analysis) is clustered at
low fold changes (Figure 1E). However, many more genes
achieve statistical significance at these small fold changes
in the N vs. Ax comparison than in the N vs. N group
(1.15–1.5 fold: 6.2% [N vs. Ax] and 1.9% [N vs. N]; Figure
1E) indicating that some low fold differences may be real.
The degree of significance (P < 0.001; 0.01, 0.05) helps
distinguish erroneous changes at these low fold levels
(Figure 1E).
Comparison of array data with the literature
Table 1 (see additional file 1) lists those genes previously
shown to be regulated in various sciatic nerve injury mod-
els using a variety techniques, as well as the expression in-
tensity, fold change and P value derived for these genes
from the arrays. Of 69 genes reported in the literature to
be expressed in the DRG (Table 1,  see additional file 1)
16 are not detected by the arrays indicating that array sen-
sitivity is an issue. Amongst these are particular functional
classes, i.e. such as G protein coupled receptors, which are
expressed at low levels [12].
25 of the 53 detected genes matched the criteria (>1.5-
fold, P < 0.05) for defining regulated genes across the N vs.
Ax comparison, and all of these were concordant with the
changes reported in the literature (Table 1, see additional
file 1). In addition 4 of the 53 detected genes whose levels
had previously been described as unchanged by axotomy
also did not vary on the arrays. Mismatches between
changes expected from the literature and the arrays may
be due to a failure of small differences to achieve statistical
significance when using a triplicate analysis. Furthermore,
differences in the timing, the nature of the injury models
used and detection methods employed between this and
earlier studies make detailed analysis of these data unfea-
sible. In order to detect true false positive and negative
rates a direct comparison needs to be made between the
array data set and transcript levels measured in samples
equivalent to those used for array hybridization.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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Northern blotting validation of transcriptional regulation
Twenty four genes detected by the arrays as being present
in the DRG and displaying up-, down- or no regulation
three days after sciatic nerve axotomy were analyzed by
replicate quantitative slot blot (Figure 2) and Northern
blot analysis (Figure 3). The genes were chosen in a non-
random fashion to encompass the range of hybridization
intensities seen on the arrays, with expression levels less
than 1000 to intensity levels greater than 10,000. Genes
were also chosen which displayed a wide range of fold-
changes and varying p values and possible functions were
taken into account (Table 2).
Figure 2 illustrates representative triplicate slot blots for
three genes with altered expression, 2 showing an increase
after axotomy (Figure 2A and 2B) and one a decrease (Fig-
ure 2C). Cyclophilin, a gene known not to alter following
axotomy[13], was used to correct for loading (Figure 2D).
Each blot was prepared from independent L4 and L5 DRG
RNA samples extracted from different groups of animals
than those used for the arrays.
Triplicate slot blots were produced for all 24 genes present
in Table 2. The concordance rate between the microarray
and slot blot fold changes for the 24 genes was 83% over-
all but concordance depended on gene expression level
Figure 2
Triplicate Northern slot blots for three genes with altered expression, 2 showing an increase after axotomy (A and B), one a
decrease (C). Cyclophilin a gene known not to alter following axotomy shows equal loading of the slot blots and acts as a nor-
malization control (see methods) (D). The histograms indicate the Northern slot blot data expressed as percentage of naïve
expression levels or above the graphs as fold change. Below the blots is the gene expression fold change calculated from the
triplicate microarray data. ** P < 0.01, * P < 0.05 (two-tailed unpaired t-test). E. Correlation between 19 separate mRNA fold-
differences calculated by triplicate slot blot and those calculated from the triplicate arrays. Linear regression line of best fit is
also plotted, scale does not represent values between -1 and 1 as fold change values within this range do not exist due to the
method of calculation (see methods).
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Figure 3
Northern blots showing differences in expression of 24 genes in naïve/control total DRG RNA (left lane) versus 3 day sciatic
nerve axotomy total DRG RNA (right lane). Gene descriptions and accession numbers are shown above each blot. The relative
positions of 28S and 18S ribosomal RNA are indicated which migrate at 4.7 kb and 1.9 kb respectively. Abbreviations: GTPcy-
clo GTP cyclohydrolase-1; Endo-1 Endothelin-1; CB-1 Cannabinoid receptor-1; CCK-B Cholecystokinin-B receptor; 53 Kd
Stromelysin-1 (matrix metalloproteinase-3); SproR Small proline rich protein-1A; ET-B Endothelin receptor-B; MSS4 Gua-
nine nucleotide releasing protein; IES-JE Monocyte chemoattractant protein-1; PKBS Peripheral benzodiazepine receptor;
5HT3 5HT3A receptor; GADD45 Growth arrest and DNA damage inducible gene alpha; PACAP Pituitary adenylate
cyclase activating peptide; Pho Cl- Phospholemman chloride channel; VGF nerve growth factor inducible protein VGF ; HFH-
2 HNF-3/fork-head homolog-2; GFRα-1 GDNF receptor alpha-1 subtype; CLP36 PDZ and LIM domain protein-1 (ELFIN);
MET-1 Metallothionein-1L; CCHL2A Calcium channel α-2 subunit; α-Macro alpha(2)-macroglobulin; Giα sub Guanine
nucleotide-binding protein G-I, α subunit; SNAP-25 Synaptosomal associated protein 25A & B.
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(Table 2). Genes expressed at low levels in the arrays tend-
ed to display fold changes that varied from that found by
the slot blots. It is likely that this is a consequence of the
unreliable average intensity estimation for low level genes
due to limited array sensitivity (Figure 1A). If genes with a
mean intensity expression level of less than 1000 are re-
moved from the analysis (top five rows, Table 2), and the
array fold changes of the remaining 19 genes are plotted
against the slot blot fold changes, a very strong correlation
is evident (linear regression r2 = 0.8567) (Figure 2E). The
concordance rate of this group is 95% (using >1.5-fold, P
< 0.05 to predict regulation). This shows that within the
bounds of array sensitivity, average fold changes for genes
found to differ significantly between triplicate control and
experimental arrays represent a reasonable estimate of the
relative changes in gene expression.
Northern blot analysis, although requiring more tissue,
both confirms that the correct transcript size is recognized
by the probe and enables splice variants to be identified
(Figure 3). All 24 genes in Table 2 were analyzed in this
way and alternate splice forms were evident for 5 genes.
A list of all the putatively regulated genes within the DRG
detected by the arrays (>1.5-fold and P < 0.05) 3 days fol-
lowing a sciatic nerve transection are given as additional
data in table 3 (see additional file 2).
In situ Hybridization
Dorsal root ganglia as well as containing the cell bodies of
primary sensory neurons also contain satellite glial cells,
Schwann cells and immune cells and it is important,
therefore to determine which of these cell types express
the regulated genes. Here we use isotopic- in situ hybridi-
Table 2: Comparison of microarray, quantitative Northern slot blot and in situ hybridization data for genes validated in this study.
Array Data Northern Data In situ Known
Descriptions Accession 
Number
Naïve Mean 
intensity ± S.D.
Axotomy Mean 
intensity ± S.D.
Fold 
change
P value Fold 
change
P value Regulation Regulation
GTP cyclohydrolase I M58364 222 ± 12 1605 ± 194 7.2 0.0064 ** 3.8 0.0000 *** ↑
Endothelin-1 M64711 538 ± 170 716 ± 34 1.3 0.2076 1.7 0.0004 ***
Cannabinoid CB1 receptor X55812 576 ± 21 388 ± 49 -1.5 0.0118 * -1.2 0.4221
Cholecystokinin-B recep-
tor
M99418 588 ± 145 534 ± 56 -1.1 0.6011 2.7 0.0008 *** ↑(31,32)
53 kD polypeptide X02601 645 ± 194 723 ± 113 1.1 0.5875 2.4 0.0433 *
Small proline-rich protein 
1a (EST195714)
AA891911 1063 ± 205 3856 ± 263 3.6 0.0002 *** 3.3 0.0267 * ↑(8)
ET-B endothelin receptor X57764 1228 ± 1015 1448 ± 1131 1.2 0.8145 1.2 0.1445
Guanine nucleotide-releas-
ing protein (MSS4)
L10336 1301 ± 335 1286 ± 174 1.0 0.9478 -1.1 0.0562
Immediate-early serum-
responsive JE (IES-JE)
X17053 1539 ± 473 3864 ± 818 2.5 0.0208 * 2.0 0.0089 ** ↑
Peripheral-type 
benzodiazepine receptor
J05122 2664 ± 314 4148 ± 459 1.6 0.0132 * 2.1 0.0078 **
5HT-3 receptor U59672 2750 ± 254 1413 ± 276 -1.9 0.0036 ** -2.6 0.0140 * ↓
Gadd45 L32591 3394 ± 195 14,021 ± 644 4.1 0.0005 *** 5.9 0.0047 **
Pituitary adenylate cyclase 
activating peptide(PACAP)
X80290 3466 ± 434 12,182 ± 290 3.5 0.0000 *** 4.6 0.0004 *** ↑(6,55)
Phopholemman chloride 
channel (EST189142)
AA799645 3629 ± 327 8094 ± 283 2.2 0.0001 *** 1.6 0.0062 **
VGF (nerve growth factor-
inducible protein)
M74223 3791 ± 619 10,200 ± 748 2.7 0.0004 *** 2.7 0.0050 ** ↑
HNF-3/fork-head 
homolog-2 (HFH-2)
L13202 3961 ± 396 3640 ± 202 -1.1 0.2994 1.3 0.0986
GFRα1(RET ligand 1) U97142 4132 ± 755 8443 ± 581 2.0 0.0019 ** 2.4 0.0029 ** ↑(45)
CLP36 (Elfin) U23769 5124 ± 532 11,527 ± 666 2.2 0.0003 *** 2.5 0.0019 **
Metallothionein-1 
(EST211851)
AI102562 5628 ± 779 6715 ± 319 1.2 0.1230 1.6 0.0321 *
Calcium channel α-2 
subunit (CCHL2A)
M86621 7267 ± 1792 25,005 ± 1485 3.4 0.0002 *** 4.7 0.0125 * ↑↑ (65)
α-2-macroglobulin M23566 8995 ± 1046 21,057 ± 3221 2.3 0.0157 * 2.6 0.0023 **
Lysozyme (EST196578) AA892775 10,702 ± 3948 26,572 ± 2127 2.5 0.0082 ** 2.9 0.0024 **
Guanine nucleotide-binding 
protein G-i, α subunit
M12672 10,728 ± 1325 10,781 ± 1099 1.0 0.9608 1.1 0.0217 *
SNAP-25A AB003991 22,532 ± 3763 16,441 ± 1731 -1.4 0.0898 -1.4 0.0486 * ↓
Key to abbreviations, * P < 0.05, ** P < 0.01, *** P < 0.001 (two-tailed unpaired t-test). Down regulated genes are expressed as negative fold changes.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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Figure 4
Darkfield photomicrographs of 6 µm thick L4 DRG sections processed for in situ hybridization with probes indicated. GTPcy-
clo, IES-JE, CCHL2A and VGF transcripts show a strong upregulation following injury compared to the naïve. SNAP25, and
5HT3 receptor mRNA show a downregulation following injury to the peripheral neurons. Scale bar = 200 µm.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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zation (ISH) to determine the cellular localization of 6
transcripts (Figure 4). All genes selected are neuronal. GT-
Pcylo, IES-JE, CCHL2A and VGF all show a marked in-
crease in the number of labeled neurons while SNAP25
and the 5HT3 receptor show a decrease in numbers and
intensity of labeled DRG neurons following axotomy (Fig-
ure 4).
Time dependent changes in transcription
The pattern of expression of four genes within the DRG
(Lysozyme, PACAP, MET-1 and SNAP25) were further
quantified across a time course of 1, 3, 7 and 14 days post
axotomy by triplicate northern slot blot (Figure 5). These
genes show diverse patterns of regulation. While lys-
ozyme, PACAP, MET-1 are all up-regulated, for MET1 this
is only transient. Identical results were found by in situ hy-
bridization (Fig. 4). Profiling changes in transcription
over time is therefore, important.
Potential roles of injury-regulated genes
Table 4 (see additional file 3) indicates the pattern of ex-
pression, class, action, and functional role for 15 previ-
ously uncharacterized, and 9 novel injury-regulated genes,
amongst the 24 validated genes. Five of these genes have
been reported in DRG neurons previously and six of the
genes are expressed in PC12 cells, a pheochromocytoma-
derived cell line that shares neural crest origin with neu-
rons of the DRG. Two genes are expressed in macrophages
and 6 in glial cells. Three genes have been reported to
show axotomy-induced regulation in non-DRG neurons
(sympathetic and motor neurons). These genes belong to
several different functional classes and from what is
known about their functional role in other cells, may have
a role in regeneration, cell survival, or alterations in sen-
sory processing after nerve injury (Table 4, see additional
file 3). Once a change in expression of the 240 genes in Ta-
ble 3 have been validated, similar analyses of their puta-
tive function need to be made in order to begin to address
Figure 5
Axotomy induced changes in expression of Lysozyme, PACAP, MET-1 and SNAP25 transcript levels over time. The histograms
indicate the triplicate Northern slot blot data expressed as percentage of naïve expression levels 1, 3, 7 and 14 days post axot-
omy. ***P < 0.001 ** P < 0.01, * P < 0.05 (two-tailed unpaired t-test).
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what role the genes play in the adaptive and maladaptive
response to nerve injury.
Global changes in transcription
The 240 genes defined as putatively regulated (>1.5-fold,
P < 0.05) within the DRG 3 days after sciatic nerve section
represent 5.1% of the detected genes, and of these 2.8%
are up-regulated and 2.3% down-regulated (Figure 6A).
These genes were assigned into functional classes and
characterized as up- and down-regulated. Some gene
classes are selectively regulated after axotomy (Figure 6B).
Genes associated with the cell cytoskeleton, positive and
negative regulators of apoptosis as well as immune mark-
ers tend to be up-regulated, whereas genes involved in
membrane excitability (ion channels) or neurotransmis-
sion (neurotransmitters and vesicle trafficking genes) tend
to be down-regulated.
Discussion
Although many studies have used microarray technology
for expression profiling, the criteria for determining puta-
tively regulated genes from such analyses remain poorly
defined, the current standard being a >2-fold difference in
replicate arrays. Using Affymetrix high-density rat oligo-
nucleotide-array data from control (naïve, non-injured)
and experimental (axotomy, 3 day post peripheral nerve
injury) DRGs, and comparing the differences detected in
control vs. control and control vs. experimental arrays, we
have explored the optimal criteria for minimizing the
false positive error rate. A >2-fold criterion alone was
found to generate a substantial proportion of potential
false positives, while also excluding many putatively regu-
lated genes. Based on significant difference for each probe
set (P < 0.05), 109 genes differed in the control vs. control
group, and 556 in the control vs. experimental group,
again a prohibitively high false positive rate (20%). How-
ever, a combination of fold and significant difference was
found to maximize the difference between control vs. con-
trol and control vs. experimental array comparisons. Us-
ing >1.5-fold and P < 0.05, 240 putatively regulated genes
were detected in the experimental group compared with
only 12 in the control group, an estimated error rate of
5%. If fold differences of 1.25 to 1.5 are included, many
more significantly different genes are recruited (219 in the
experimental vs. 41 in the control comparison) reducing
the potential false negative rate. At the same time, the es-
timated false positive error rate rises to 11.5 %, still lower
than the 2-fold alone error. Producing a reduction in false
positive without also producing false negative differences
requires the use both of fold and significant difference.
The established 2-fold criterion is much too conservative;
when using replicate arrays with pooled samples from
multiple animals to reduce biological variation, it loses
over 50% of putatively regulated genes and fails to elimi-
nate false positives. The very high concordance rate found
between genes predicted from the array analysis to be reg-
ulated and measurements of mRNA for 24 genes by quan-
titative Northern slot blots and in situ hybridization,
validates utilization of a two dimensional matrix of fold
and significant difference.
One problem with oligonucleotide arrays is sensitivity.
Some groups of transcripts, particularly GPCRs, including
the opiate receptors, which are expressed in the DRG, [14]
fall below the microarray detection threshold. Lack of sen-
sitivity may result from technical issues such as poor
probe performance [11] or low copy number transcripts.
Tissue heterogeneity and neuronal subpopulation-re-
stricted gene expression may lower the concentration of a
transcript in the total RNA sample to below detection
threshold [10].
Recently Xiao et al [9] published a study using 7.5 K cDNA
arrays to analyze genes regulated in the DRG 2, 7, 14 and
28 days following sciatic nerve axotomy. Of the genes list-
ed in Table 4, seven were found in both studies (Peripher-
al Benzodiazepine receptor, 5HT3, Gadd45, CLP36,
Lysozyme, SNAP25 and VGF). Of those genes whose ex-
pression was analyzed across time in this study (Figure 5)
two, Lysozyme and SNAP25, were also detected by Xiao et
al [9]. Both genes show very similar expression patterns
over time in the two studies.
In a different cDNA array study, also recently published,
16 genes were identified to be regulated by at least 2-fold
one week after sciatic axotomy [8]. Of these, seven were
also identified by our study. Five of the non-concordant
genes were not represented by known probe sets on the ar-
ray used here. Others changed, but did not reach statistical
significance, and likely represented differences in regula-
tion levels relative to the time points used (1 week as op-
posed to 3 days). One gene verified in this study, the small
proline-rich protein 1A (Table 2), was characterized in de-
tail by Bonilla et al, who show that it colocalizes with fil-
amentous actin in membrane ruffles and augments
axonal outgrowth [8].
Comparison of the global lists of regulated genes between
this study and other reports are complicated by the differ-
ing criteria used to identify regulated genes in the different
studies. However, it is encouraging to note that a reason-
able number of genes have been cross identified in three
separate array studies looking at the effects of peripheral
nerve injury on dorsal root ganglion gene expression,
pointing to the reliability of array technologies across dif-
fering platforms.
Why is the number of genes regulated in sensory neurons
after peripheral nerve injury so large? The injury consti-
tutes an enormous stress to the cell and also deprives itBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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Figure 6
Percentage of detected genes regulated above 1.5-fold (P < 0.05) with the proportion up and down regulated also shown (A).
Genes regulated above 1.5-fold (P < 0.05) were classified into functional classes, plotted are the percent of up and down regu-
lated genes respectively in each functional class (B).
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from contact with its normal target-derived neurotrophic
support. Both of these events represent perturbations
from normal cellular functioning that require a variety of
compensatory responses. A major issue is cell survival. In-
jured adult DRG neurons do not die after axonal injury
[15] as a result of the upregulation of cell survival factors
such as the small heat shock protein HSP27 [16]. We now
find several genes that could have a survival-promoting
role, including the peripheral benzodiazepine receptor,
whose agonists are potent antiapoptotic compounds [17],
GADD45A, which maintains genomic stability and ap-
pears to be anti-apoptotic in neurons after ischemic dam-
age [18], metallothionein 1L, which is a free radical
scavenger [19], GTP cyclohydrolase 1, which is obligatory
for the actions of NGF on PC12 cells [20], and IES-JE
(MCP-1) which attracts macrophages, which in turn have
been reported to have a role in neuronal survival [21].
Neurons with axons in the peripheral nervous system can
successfully regenerate when injured [22]. This is in part
due to an environment permissive for axonal growth but
also due to the upregulation of regeneration-associated
genes (RAGs) which increase intrinsic growth capacity
[23]. Three examples of RAGs are GAP-43 and CAP-23
[24] and sprp1A [8]. We now find several other potential
candidates including; α2 macroglobulin, CLP36, and VGF
all of which have been described to promote neurite out-
growth or interact with the cytoskeleton in a way that may
promote regeneration (see Table 4 [additional file 3] for
references). MMP3 also known as 53 kD polypeptide,
transin or stromelysin-1, a secreted protease, may facili-
tate neurite growth by dissolving the extracellular matrix
of the basal lamina at the growing tip of the axon (see Ta-
ble 4 for references).
Sensory neurons react to peripheral nerve injury by in-
creasing their excitability, changing their constitutive syn-
aptic transmitter profile and even their synaptic contacts
in the spinal cord. Interestingly, an analysis of the func-
tional classes of the genes differentially expressed (Figure
6) reveals the contribution that alterations in transcrip-
tion make to these processes. Several of these changes are
maladaptive in the sense that they contribute to the gen-
eration of the abnormal sensations that constitute neuro-
pathic pain, by producing ectopic spontaneous activity
into the CNS, altering synaptic drive, increasing excitabil-
ity and diminishing inhibitory action in the dorsal horn
of the spinal cord, and by making novel synaptic contacts
with inappropriate neurons [1,4]. A number of the injury-
regulated genes we describe here may contribute directly
to this altered sensory processing; CB1 receptor, VGF, the
phospholemman ion channel, SNAP25 A, endothelin-1
and the ligand-gated 5-HT3 receptor (Table 4, see addi-
tional file 3). We have only validated a small fraction of
the putatively regulated genes detected by the arrays. Our
analysis indicates that at a conservative estimate over two
hundred genes (240 genes, >1.5-fold, P < 0.05) are regu-
lated by the injury. These include genes of a number of
distinct functional classes, some of which appear to
change in a uniform way. Ion channels and neurotrans-
mitter related genes tend to decrease their expression
while those associated with the cytoskeleton increase. This
raises the possibility that numbers of different genes may
be regulated together by common changes in signal trans-
duction and transcription induced by the injury, and con-
tribute in this way to the coordinated changes that
constitute the axotomy response.
Discovering and validating regulated genes by array anal-
ysis is clearly only the first step in elucidating their func-
tional role. An evaluation of the cellular localization and
distribution of the gene product as well as loss and gain of
function manipulations in vitro and in vivo are required.
Functional studies cannot yet be performed at a high
throughput level and this represents one of the major lim-
iting factors in analyzing the large numbers of candidate
genes identified by microarray analysis. Elucidating the
specific role of genes regulated in sensory neurons after
peripheral nerve injury will provide insight though into
many major biological issues including cell survival,
growth, intercellular communication and the factors that
contribute to sensory abnormalities. Microarray technolo-
gy provides a powerful tool for beginning this analysis in
a high throughput mode by revealing the extent of change
in neuronal gene expression. Such analysis requires repli-
cate measures to minimize variability, calculation of fold
and significant differences to detect regulated genes with
minimal false positive and negative confounders and val-
idation of individual genes.
Conclusions
1: A comparison of two naïve (control) triplicate data sets
allowed determination of the inherent variation present
in the oligonucleotide array data. Analysis revealed a rela-
tively high false positive error rate in the naïve versus ax-
otomy (experimental) comparisons (16%) when using
only a 2-fold criterion for regulated gene detection.
2: When statistical significance (P < 0.05) was combined
with a fold difference of greater than 1.5 as the criteria for
detecting putatively regulated genes, not only was the es-
timated false positive error substantially reduced (to 5%),
but also many more genes were identified compared with
the established 2-fold criterion, in the naïve versus axoto-
my comparison (240 as opposed to 178 genes).
3: All 240 genes displaying a fold change of greater than
1.5 and a P-value of less than 0.05 are listed.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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4: To validate these findings we performed quantitative
triplicate slot blots for 24 genes, enabling a direct compar-
ison between the statistically analyzed array data and the
mRNA measurements. These comparisons show strong
concordance between putative and actual regulation as
well as a direct relationship between array fold change and
mRNA fold change.
5: Some genes were further quantified across a time course
of 1, 3, 7 and 14 days post axotomy. These genes show di-
verse patterns of regulation in response to nerve injury
and underlie the importance of including time as a di-
mension in any expression profile study.
6: Genes detected from the arrays, as being likely to be reg-
ulated, were assigned to functional groups. These data
suggest the reorganization of cell structural components
following peripheral nerve injury, activation of genes ex-
pressed by immune and inflammatory cells, and a down-
regulation of genes involved in neurotransmission.
Methods
Surgical procedures
All procedures were performed in accordance with Massa-
chusetts General Hospital animal care regulations. Adult
male Sprague Dawley rats (200–300 g) were anesthetized
with halothane. For the sciatic nerve transection (axoto-
my), the left sciatic nerve was exposed at the mid thigh
level, ligated with 3/0 silk and sectioned distally. The
wound was sutured in two layers, and the animals were al-
lowed to recover.
Tissue and RNA preparation
Animals were terminally anesthetized with CO2, the L4
and L5 DRGs rapidly removed, and stored at -80°C. Total
RNA was extracted from homogenized DRG samples us-
ing acid phenol extraction (TRIzol reagent, Gibco-BRL).
RNA concentration was evaluated by A260 measurement
and quality assessed by electrophoresis on a 1.5% agarose
gel. Each RNA sample used for hybridization of each array
was extracted from rat L4 and L5 DRGs (10 ganglia pooled
from 5 animals, per sample).
Microarray Analysis
Affymetrix rat genome U34A oligonucleotide microarrays,
representing 8799 known transcripts and expressed se-
quence tags (ESTs), were used (Santa Clara, CA  [http://
www.affymetrix.com]). Oligonucleotides are arranged in
pairs corresponding to different regions of the target
mRNA with multiple probe pairs. Each probe pair consists
of a 25 nucleotide perfect match (PM) to the target region
coupled with a 25-mer with a single mismatch (MM) at
the 13th nucleotide. Transcript abundance is estimated by
analysis of signal intensity of the PM/MM pairs. The arrays
are hybridized with biotin-labeled cRNA, prepared as per
standard Affymetrix protocol. Briefly, total RNA (8 µg)
from DRGs was reverse transcribed using an oligo-dT
primer coupled to a T7 RNA polymerase binding site.
Double-stranded cDNA was made and biotinylated-cRNA
synthesized using T7 polymerase. The cRNA was hybrid-
ized for 16 hours to an array, followed by binding with a
streptavidin-conjugated fluorescent marker, and then in-
cubated with a polyclonal anti-streptavidin antibody cou-
pled to phycoerythrin as an amplification step. Following
washing, the chips were scanned with a Hewlett-Packard
GeneArray laser scanner and data analyzed using Gene-
Chip software. External standards were included to con-
trol for hybridization efficiency and sensitivity.
Hybridization levels for each species of mRNA detected
on the arrays are expressed by intensity (signal) and as
present (P), marginal (M) or absent (A) calls, calculated
by Affymetrix software (MAS 5.0, α1 = 0.04 α2 = 0.06). To
normalize the array data standard Affymetrix protocols
were employed, each array was scaled to a target signal of
2500 across all probe sets (MAS 5.0).
The arrays were grouped for two comparisons: two tripli-
cate sets of naïve data compared with one another, and
one triplicate naïve set compared with one triplicate post-
axotomy set. The individual naïve arrays included in each
triplicate set were picked randomly. A probe set was deter-
mined undetected if it received an A call in all of the six
arrays involved in the comparison. Detected were Present
or Marginal by MAS5.0 in at least one array for each anal-
ysis. Mean signal and standard deviation were calculated
for each detected probe set. The p-value for rejecting the
null hypothesis that the mean signals were equal between
the two triplicate sets was calculated using an unpaired,
two-tailed t-test for independent samples with unequal
variance (Satterthwaite's method). Fold-differences be-
tween the mean signals (A and B) in the two triplicate sets
were calculated as max(A, B) / min(A, B) with down regu-
lation relative to naïve expressed as negative.
cDNA Probe production
To generate specific probes for Northern blot hybridiza-
tion experiments, primers based on the rat accession
number provided by Affymetrix were designed, primer
pairs were chosen using the Primer3 software  [http://
www-genome.wi.mit.edu/] from the 1000 most 3' nucle-
otides within each accession sequence. PCR was per-
formed on cDNA reverse transcribed from total RNA,
extracted from lumbar DRGs, using poly-dT as a primer to
obtain cDNA fragments (141 to 596 bp). These fragments
were subsequently cloned into the PCRII vector (TA clon-
ing Kit, Invitrogen) and the identity of each was con-
firmed by sequencing in both directions. These cDNAs
were gel-purified and used to produce 32P-labeled cDNA
probes (Prime-It kit, Stratagene).BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/16
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Northern blot analysis
Total RNA was size separated by electrophoresis on a
1.5% agarose/formaldehyde gel (10 µg of total RNA per
lane) and transferred to a Hybond N+ nylon membrane.
Membranes were hybridized with labeled-probes (see
above) in ExpressHyb (Clontech) overnight at 65°C,
washed and exposed to X-ray film with an intensifying
screen at -80°C.
Slot Blots
Total RNA (1.25 µg) was directly transferred to Hybond
N+ nylon membrane under vacuum using a Hoefer PR648
slot blot apparatus (Amersham Pharmacia Biotech) as de-
scribed in [25]. The slot blots were produced in batches of
ten from a relevant master mix and probed with the same
cDNA under the same conditions as described for North-
ern blot analysis. Levels of hybridization were quantified
using the 24450 phosphorimager system (Molecular Dy-
namics, Sunnyvale CA.). One of the blots in each batch
was probed for cyclophilin to act as a loading control. The
other nine blots were used to measure the expression lev-
els of individual genes. Loading levels between samples
on each blot were normalized using the cyclophilin levels
from the control blot.
Isotopic in situ Hybridization
DRGs were rapidly removed, embedded in OCT (Tissue
Tek) and frozen. Sections were cut serially at 6 µm. Isotop-
ic-in situ hybridization was carried out using forty-eight
base pair oligonucleotide probes, designed to have 50%
G-C content and be complementary to the mRNAs whose
accession numbers were provided by Affymetrix. Probes
were 3'-end labeled with 35S or 33P-dATP using a terminal
transferase reaction and hybridization carried out [26].
Autoradiograms were generated by dipping slides in NTB2
nuclear track emulsion and storing in the dark at 4°C. Sec-
tions were exposed for 1–8 weeks (depending on the
abundance of transcript), developed, fixed and viewed un-
der darkfield using a fiber-optic darkfield stage adapter
(MVI). Controls to confirm specificity of oligonucleotide
probes included hybridization of sections with labeled
probe with a 1,000-fold excess of cold probe or labeled
probe with a 1,000-fold excess of another, dissimilar cold
probe of the same length and similar G-C content.
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